Systematic antibody and antigen-based proteomic profiling with microarrays
暂无分享,去创建一个
Peter Nilsson | Mathias Uhlén | Jochen M Schwenk | M. Uhlén | P. Nilsson | J. Schwenk | M. Neiman | B. Ayoglu | A. Häggmark | Burcu Ayoglu | Maja Neiman | Anna Häggmark | Ulrika Igel | Ulrika Igel | Anna Häggmark
[1] Baogang J. Xu. Combining laser capture microdissection and proteomics: Methodologies and clinical applications , 2010, Proteomics. Clinical applications.
[2] Yongchao Ge,et al. Development of a novel peptide microarray for large-scale epitope mapping of food allergens. , 2009, The Journal of allergy and clinical immunology.
[3] M. Sánchez-Carbayo,et al. Identification of Tumor-associated Autoantigens for the Diagnosis of Colorectal Cancer in Serum Using High Density Protein Microarrays* , 2009, Molecular & Cellular Proteomics.
[4] A. Fitzpatrick,et al. Impact of Freeze-thaw Cycles and Storage Time on Plasma Samples Used in Mass Spectrometry Based Biomarker Discovery Projects , 2005, Cancer informatics.
[5] Marina Cretich,et al. Protein and peptide arrays: recent trends and new directions. , 2006, Biomolecular engineering.
[6] Dieter Stoll,et al. Protein microarrays and multiplexed sandwich immunoassays: what beats the beads? , 2004, Combinatorial chemistry & high throughput screening.
[7] H. Huland,et al. Stage‐dependent increase of orosomucoid and zinc‐alpha2‐glycoprotein in urinary bladder cancer , 2005, Proteomics.
[8] Tibor Kozár,et al. Glycan and lectin microarrays for glycomics and medicinal applications , 2010, Medicinal research reviews.
[9] Satoshi Nishizuka,et al. Protein and lysate array technologies in cancer research. , 2008, Biotechnology advances.
[10] M. Taussig,et al. Protein microarrays: high-throughput tools for proteomics , 2009, Expert review of proteomics.
[11] Urs Eppenberger,et al. Protein chip based miniaturized assay for the simultaneous quantitative monitoring of cancer biomarkers in tissue extracts , 2006, Proteomics.
[12] G. Thallinger,et al. Novel functional profiling approach combining reverse phase protein microarrays and human 3‐D ex vivo tissue cultures: Expression of apoptosis‐related proteins in human colon cancer , 2009, Proteomics.
[13] Y. Baba,et al. Efficiency of cell-free protein synthesis based on a crude cell extract from Escherichia coli, wheat germ, and rabbit reticulocytes. , 2008, Journal of biotechnology.
[14] F. Ahmed. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry. , 2009, Journal of separation science.
[15] Dieter Stoll,et al. Protein microarrays for diagnostic assays , 2009, Analytical and bioanalytical chemistry.
[16] Debashis Ghosh,et al. Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.
[17] Eshel Ben-Jacob,et al. Organization of the autoantibody repertoire in healthy newborns and adults revealed by system level informatics of antigen microarray data , 2009, Proceedings of the National Academy of Sciences.
[18] J. Tissot,et al. Plasma/serum proteomics: pre-analytical issues , 2007, Expert review of proteomics.
[19] Michael J Taussig,et al. Printing protein arrays from DNA arrays , 2008, Nature Methods.
[20] Mingyue He,et al. Cell-free protein synthesis: applications in proteomics and biotechnology. , 2008, New biotechnology.
[21] Jian-ying Zhang,et al. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors , 2010, Expert review of molecular diagnostics.
[22] D. T. Wong,et al. Human body fluid proteome analysis , 2006, Proteomics.
[23] E. Diamandis,et al. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies , 2008, Nature Clinical Practice Oncology.
[24] H. Sampson,et al. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. , 2008, The Journal of allergy and clinical immunology.
[25] Z. Namiot,et al. MUC 1 mucin content in gastric juice of duodenal ulcer patients: effect of Helicobacter pylori eradication therapy , 2007, Clinical and Experimental Medicine.
[26] Yoav Benjamini,et al. Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..
[27] H. Dihazi,et al. Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as a differentially excreted protein in diabetic nephropathy patients. , 2007, Clinical chemistry.
[28] S. Schreiber,et al. Printing proteins as microarrays for high-throughput function determination. , 2000, Science.
[29] Peter B. McGarvey,et al. Protein Bioinformatics Infrastructure for the Integration and Analysis of Multiple High-Throughput “omics” Data , 2010, Adv. Bioinformatics.
[30] I. Gipson,et al. Assay of mucins in human tear fluid. , 2007, Experimental eye research.
[31] Philip J R Day,et al. Advances and perspectives in aptamer arrays. , 2009, Integrative biology : quantitative biosciences from nano to macro.
[32] A. Pich,et al. Mass spectrometry-based methods for biomarker detection and analysis. , 2005, Drug discovery today. Technologies.
[33] J. Casal,et al. Identification of cancer autoantigens in serum: toward diagnostic/prognostic testing? , 2010, Molecular Diagnosis & Therapy.
[34] M. Borggrefe,et al. Effect of freezing method and storage at -20 degrees C and -70 degrees C on prothrombin time, aPTT and plasma fibrinogen levels. , 2009, Thrombosis research.
[35] M. Uhlén,et al. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain , 1997, Nature Biotechnology.
[36] Bonnie Bruce,et al. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[37] G. Perry,et al. Antigen–antibody dissociation in Alzheimer disease: a novel approach to diagnosis , 2008, Journal of neurochemistry.
[38] Sanjeeva Srivastava,et al. Cell‐free synthesis‐based protein microarrays and their applications , 2010, Proteomics.
[39] J. Hoheisel,et al. Dual-color Proteomic Profiling of Complex Samples with a Microarray of 810 Cancer-related Antibodies* , 2010, Molecular & Cellular Proteomics.
[40] H. Senn,et al. Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics. , 2006, Analytical chemistry.
[41] Carsten Grötzinger,et al. Deciphering the Antibodyome - Peptide Arrays for Serum Antibody Biomarker Diagnostics , 2009 .
[42] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[43] Yi Dong,et al. Ultrasonographic feature selection and pattern classification for cervical lymph nodes using support vector machines , 2007, Comput. Methods Programs Biomed..
[44] Mahesh Uttamchandani,et al. Small molecule microarrays: recent advances and applications. , 2005, Current opinion in chemical biology.
[45] Yibing Yan,et al. Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays , 2008, Molecular Cancer Therapeutics.
[46] L. Gold,et al. Aptamers as therapeutic and diagnostic agents. , 2000, Journal of biotechnology.
[47] Anirban P. Mitra,et al. Molecular markers for bladder cancer: the road to a multimarker approach , 2007, Expert review of anticancer therapy.
[48] M. Chatterjee,et al. Discovery of antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput. , 2009, Methods in molecular biology.
[49] Thomas O Joos,et al. Miniaturized parallelized sandwich immunoassays. , 2008, Methods in molecular biology.
[50] S. Hanash,et al. Occurrence of autoantibodies to annexin I, 14-3-3 theta and LAMR1 in prediagnostic lung cancer sera. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] H. Frierson,et al. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. , 2006, The Lancet. Oncology.
[52] J. Schwenk,et al. Characterization of PrEST-based antibodies towards human Cytokeratin-17. , 2009, Journal of immunological methods.
[53] A. Branscum,et al. Accounting for response misclassification and covariate measurement error improves power and reduces bias in epidemiologic studies. , 2010, Annals of epidemiology.
[54] R. Falk,et al. Approaches for systematic proteome exploration. , 2007, Biomolecular engineering.
[55] T. Peakman,et al. Design and implementation of a high-throughput biological sample processing facility using modern manufacturing principles. , 2008, International journal of epidemiology.
[56] John R Yates,et al. Identifying components of protein complexes in C. elegans using co-immunoprecipitation and mass spectrometry. , 2010, Journal of proteomics.
[57] Fay Betsou,et al. Biobanking for better healthcare , 2008, Molecular oncology.
[58] P. Pansri,et al. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens , 2009, BMC biotechnology.
[59] Yan Zhang,et al. Novel autoimmune hepatitis-specific autoantigens identified using protein microarray technology. , 2010, Journal of proteome research.
[60] Jerzy Silberring,et al. Biomarker discovery and clinical proteomics. , 2010, Trends in analytical chemistry : TRAC.
[61] R. Frank,et al. Epitope mapping of pathogenic Leptospira LipL32 , 2009, Letters in applied microbiology.
[62] Pierre Baldi,et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[63] T. Peterson,et al. Membrane protein expression: no cells required. , 2009, Trends in biotechnology.
[64] Xiaobo Yu,et al. Protein Microarrays for Personalized Medicine , 2010, Clinical chemistry.
[65] K. Anderson,et al. Rapid detection of antibodies in sera using multiplexed self-assembling bead arrays. , 2009, Journal of immunological methods.
[66] M. Uhlén,et al. Antibodypedia, a Portal for Sharing Antibody and Antigen Validation Data*S , 2008, Molecular & Cellular Proteomics.
[67] Fredrik Y Frejd,et al. Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications , 2010, FEBS letters.
[68] Sanjeeva Srivastava,et al. Applications of protein microarrays for biomarker discovery , 2008, Proteomics. Clinical applications.
[69] Hendrik Neubert,et al. An immunoaffinity liquid chromatography-tandem mass spectrometry assay for the quantitation of matrix metalloproteinase 9 in mouse serum. , 2010, Analytical biochemistry.
[70] Sophia Hober,et al. High‐throughput protein production – Lessons from scaling up from 10 to 288 recombinant proteins per week , 2009, Biotechnology journal.
[71] T. Joos,et al. Microsphere-based co-immunoprecipitation in multiplex. , 2009, Analytical biochemistry.
[72] Yanhui Hu,et al. Next generation high density self assembling functional protein arrays , 2008, Nature Methods.
[73] G. Auer,et al. Proteomics in clinical prostate research , 2007, Proteomics. Clinical applications.
[74] Kenji Usui,et al. Protein‐Detecting Microarrays: Current Accomplishments and Requirements , 2005, Chembiochem : a European journal of chemical biology.
[75] E. Petricoin,et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.
[76] R. Niessner,et al. Efficient hybridoma screening technique using capture antibody based microarrays. , 2009, Analytical chemistry.
[77] Gil Mor,et al. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays , 2007, Proceedings of the National Academy of Sciences.
[78] Thomas Brinker,et al. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease , 2008, Cerebrospinal Fluid Research.
[79] Sung‐Min Ahn,et al. Body fluid proteomics: Prospects for biomarker discovery , 2007, Proteomics. Clinical applications.
[80] M. Caron,et al. Cancer Immunomics Using Autoantibody Signatures for Biomarker Discovery* , 2007, Molecular & Cellular Proteomics.
[81] P. Nilsson,et al. Selective IgA deficiency in early life: association to infections and allergic diseases during childhood. , 2009, Clinical immunology.
[82] Yingchun Zhao,et al. Quantitative proteomics and biomarker discovery in human cancer , 2009, Expert review of proteomics.
[83] P. Riegman,et al. Biobanking for Interdisciplinary Clinical Research , 2007, Pathobiology.
[84] Rachel Ostroff,et al. The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array. , 2010, Journal of proteomics.
[85] M. Bradley,et al. Functional peptide arrays for high-throughput chemical biology based applications. , 2007, Current opinion in biotechnology.
[86] Ziding Feng,et al. Optimized Normalization for Antibody Microarrays and Application to Serum-Protein Profiling*S , 2005, Molecular & Cellular Proteomics.
[87] R. Lewensohn,et al. Affinity prefractionation for MS‐based plasma proteomics , 2009, Proteomics.
[88] Zhi-Hua Yang,et al. Selection and affinity maturation of human antibodies against rabies virus from a scFv gene library using ribosome display. , 2009, Journal of biotechnology.
[89] Fridtjof Lund-Johansen,et al. Antibody Array Analysis with Label-based Detection and Resolution of Protein Size *S , 2009, Molecular & Cellular Proteomics.
[90] K. Papp,et al. Antigen microarrays: descriptive chemistry or functional immunomics? , 2010, Trends in immunology.
[91] S. Lehmann,et al. Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better? , 2009, Journal of proteomics.
[92] Henning Hermjakob,et al. A Reagent Resource to Identify Proteins and Peptides of Interest for the Cancer Community , 2006, Molecular & Cellular Proteomics.
[93] N. Halama,et al. Seromic profiling of ovarian and pancreatic cancer , 2010, Proceedings of the National Academy of Sciences.
[94] Michael J Taussig,et al. In situ synthesis of protein arrays. , 2008, Current opinion in biotechnology.
[95] H. Mischak,et al. Discovery and validation of urinary biomarkers for prostate cancer , 2008, Proteomics. Clinical applications.
[96] Yanqing Zhang,et al. Development of Two-Stage SVM-RFE Gene Selection Strategy for Microarray Expression Data Analysis , 2007, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[97] Mark B Gerstein,et al. Robust-linear-model normalization to reduce technical variability in functional protein microarrays. , 2009, Journal of proteome research.
[98] Ulf Landegren,et al. Sensitive Plasma Protein Analysis by Microparticle-based Proximity Ligation Assays* , 2009, Molecular & Cellular Proteomics.
[99] I. Fodor,et al. Statistical Analysis of Variation in the Human Plasma Proteome , 2010, Journal of biomedicine & biotechnology.
[100] B. Luft,et al. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays. , 2008, Microbial pathogenesis.
[101] B. Haab. Methods and applications of antibody microarrays in cancer research , 2003, Proteomics.
[102] M. Baker,et al. High‐abundance protein depletion: Comparison of methods for human plasma biomarker discovery , 2010, Electrophoresis.
[103] Peter Filzmoser,et al. Outlier identification in high dimensions , 2008, Comput. Stat. Data Anal..
[104] John Spertus,et al. Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study. , 2009, Clinical chemistry.
[105] Xuegong Zhang,et al. Recursive SVM feature selection and sample classification for mass-spectrometry and microarray data , 2006, BMC Bioinformatics.
[106] Axel Kowald,et al. Profiling of Alopecia Areata Autoantigens Based on Protein Microarray Technology* , 2005, Molecular & Cellular Proteomics.
[107] K. Kwong,et al. Generation, affinity maturation, and characterization of a human anti-human NKG2D monoclonal antibody with dual antagonistic and agonistic activity. , 2008, Journal of molecular biology.
[108] P. Brown,et al. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.
[109] P. Felgner,et al. Defining the humoral immune response to infectious agents using high-density protein microarrays. , 2010, Future microbiology.
[110] Designing and implementing a large-scale automated -80 degrees C archive. , 2008, International journal of epidemiology.
[111] Hiroko Yamada,et al. Human protein factory for converting the transcriptome into an in vitro–expressed proteome , 2008, Nature Methods.
[112] B. Trathnigg,et al. Characterization of poly(ethylene glycol)-b-poly(epsilon-caprolactone) by two-dimensional liquid chromatography. , 2009, Journal of separation science.
[113] William C Reinhold,et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[114] Volker Stadler,et al. High-density peptide arrays. , 2009, Molecular bioSystems.
[115] William Stafford Noble,et al. How does multiple testing correction work? , 2009, Nature Biotechnology.
[116] Kai Hilpert,et al. Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion , 2007, Nature Protocols.
[117] S. Hanash,et al. Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study , 2006, Nature Biotechnology.
[118] Andreas Plückthun,et al. A designed ankyrin repeat protein evolved to picomolar affinity to Her2. , 2007, Journal of molecular biology.
[119] M. Uhlén,et al. Epitope mapping of antibodies using bacterial surface display , 2008, Nature Methods.
[120] J. Schneider-Mergener,et al. High-content peptide microarrays for deciphering kinase specificity and biology. , 2004, Angewandte Chemie.
[121] M. Ruegg,et al. Reverse protein arrays as novel approach for protein quantification in muscular dystrophies , 2010, Neuromuscular Disorders.
[122] F. Pontén,et al. The Human Protein Atlas—a tool for pathology , 2008, The Journal of pathology.
[123] Gary A. Churchill,et al. Randomization in Laboratory Procedure Is Key to Obtaining Reproducible Microarray Results , 2008, PloS one.
[124] David H Jackson,et al. Banking of clinical samples for proteomic biomarker studies: A consideration of logistical issues with a focus on pre‐analytical variation , 2010, Proteomics. Clinical applications.
[125] F. Bischoff,et al. Particle‐Based Synthesis of Peptide Arrays , 2009, Chembiochem : a European journal of chemical biology.
[126] P. Stinissen,et al. Autoantibody Profiling in Multiple Sclerosis Reveals Novel Antigenic Candidates1 , 2008, The Journal of Immunology.
[127] R. Aebersold,et al. Mass Spectrometry and Protein Analysis , 2006, Science.
[128] Ioan Tabus,et al. Robust estimation of protein expression ratios with lysate microarray technology , 2005, Bioinform..
[129] S. Hanash,et al. Mining the plasma proteome for cancer biomarkers , 2008, Nature.
[130] Ana Fernández-Somoano,et al. The null hypothesis significance test in health sciences research (1995-2006): statistical analysis and interpretation , 2010, BMC medical research methodology.
[131] N. Anderson,et al. A List of Candidate Cancer Biomarkers for Targeted Proteomics , 2006, Biomarker insights.
[132] H. Lehrach,et al. Recent advances of protein microarrays , 2005, Current Opinion in Chemical Biology.
[133] Ruedi Aebersold,et al. Targeted proteomic strategy for clinical biomarker discovery , 2009, Molecular oncology.
[134] T. Joos,et al. Sequential Multiplex Analyte Capturing for Phosphoprotein Profiling* , 2010, Molecular & Cellular Proteomics.
[135] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[136] Hans Lilja,et al. Circulating biomarkers for prostate cancer , 2007, World Journal of Urology.
[137] R. Heinzen,et al. Candidate Antigens for Q Fever Serodiagnosis Revealed by Immunoscreening of a Coxiella burnetii Protein Microarray , 2008, Clinical and Vaccine Immunology.
[138] E. Slate,et al. Overcoming the Effects of Matrix Interference in the Measurement of Urine Protein Analytes , 2012, Biomarker insights.
[139] M. Uhlén,et al. Antibody suspension bead arrays within serum proteomics. , 2008, Journal of proteome research.
[140] Belinda Bullard,et al. High throughput production of mouse monoclonal antibodies using antigen microarrays , 2005, Proteomics.
[141] Arlo Z. Randall,et al. Profiling humoral immune responses to P. falciparum infection with protein microarrays , 2008, Proteomics.
[142] G. Mills,et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.
[143] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[144] Dina Aronzon,et al. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. , 2008, Journal of proteome research.
[145] R. Ekins,et al. Multi-analyte immunoassay. , 1989, Journal of pharmaceutical and biomedical analysis.
[146] P. Bauer,et al. Model Selection Based on FDR-Thresholding Optimizing the Area under the ROC-Curve , 2009, Statistical applications in genetics and molecular biology.
[147] P. Davidsson,et al. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples , 2005, Proteomics.
[148] J. Lenormand,et al. Production of membrane proteins using cell–free expression systems , 2007, Expert review of proteomics.
[149] C. Borrebaeck,et al. Antibody microarray analysis of directly labelled complex proteomes. , 2008, Current opinion in biotechnology.
[150] M. Mann,et al. Super-SILAC mix for quantitative proteomics of human tumor tissue , 2010, Nature Methods.
[151] R. Longhi,et al. Peptide microarrays for the characterization of antigenic regions of human chromogranin A , 2005, Proteomics.
[152] R. Tibshirani,et al. Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis , 2009, Arthritis research & therapy.
[153] E. Lundberg,et al. A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies* , 2008, Molecular & Cellular Proteomics.
[154] Hans Lehrach,et al. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease‐associated protein chip , 2006, Proteomics.
[155] H. Grönberg,et al. Toward Next Generation Plasma Profiling via Heat-induced Epitope Retrieval and Array-based Assays* , 2010, Molecular & Cellular Proteomics.
[156] Joakim Lundeberg,et al. Serum Microarrays for Large Scale Screening of Protein Levels *S , 2005, Molecular & Cellular Proteomics.
[157] David E. Gloriam,et al. ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome , 2007, Nature Methods.
[158] J. Barratt,et al. Urine proteomics: the present and future of measuring urinary protein components in disease , 2007, Canadian Medical Association Journal.
[159] Dieter Stoll,et al. Cell microarrays: an emerging technology for the characterization of antibodies. , 2002, BioTechniques.
[160] W. Robinson,et al. Antigen arrays for antibody profiling. , 2006, Current opinion in chemical biology.
[161] Fredrik Karpe,et al. Comparative protein profiling of serum and plasma using an antibody suspension bead array approach , 2010, Proteomics.
[162] F. Pontén,et al. Towards a human proteome atlas: High‐throughput generation of mono‐specific antibodies for tissue profiling , 2005, Proteomics.
[163] S. Kingsmore. Multiplexed protein measurement: technologies and applications of protein and antibody arrays , 2006, Nature Reviews Drug Discovery.
[164] Eugene A. Kapp,et al. Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.
[165] Gregor Kijanka,et al. Protein arrays as tools for serum autoantibody marker discovery in cancer. , 2009, Journal of proteomics.
[166] T. Veenstra,et al. The Human Plasma Proteome , 2004, Molecular & Cellular Proteomics.
[167] M. Uhlén. Mapping the human proteome using antibodies. , 2007, Molecular & cellular proteomics : MCP.
[168] Hwee Tong Tan,et al. Serum autoantibodies as biomarkers for early cancer detection , 2009, The FEBS journal.
[169] D. Burton,et al. Efficient recovery of high-affinity antibodies from a single-chain Fab yeast display library. , 2009, Journal of molecular biology.
[170] A. Turner,et al. Molecularly imprinted polymers for the recognition of proteins: the state of the art. , 2007, Biosensors & bioelectronics.
[171] Yeung Sam Hung,et al. Statistical Applications in Genetics and Molecular Biology , 2010 .
[172] Yiling Lu,et al. Use of Reverse Phase Protein Microarrays and Reference Standard Development for Molecular Network Analysis of Metastatic Ovarian Carcinoma* , 2005, Molecular & Cellular Proteomics.
[173] M. A. Bopp,et al. Zeptosens' protein microarrays: A novel high performance microarray platform for low abundance protein analysis , 2002, Proteomics.
[174] Lello Zolla,et al. Blood-related proteomics. , 2010, Journal of proteomics.
[175] M. O’Connor-McCourt,et al. Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker , 2009, Proteome Science.
[176] Markus Ehrat,et al. Antibody‐based proteomics , 2009, The FEBS journal.
[177] B. Nelson,et al. Protein microarrays as an application for disease biomarkers , 2009, Proteomics. Clinical applications.
[178] Jeffrey R. Whiteaker,et al. Head-to-head comparison of serum fractionation techniques. , 2007, Journal of proteome research.
[179] Markus F Templin,et al. Expanding assay dynamics: a combined competitive and direct assay system for the quantification of proteins in multiplexed immunoassays. , 2008, Clinical chemistry.
[180] John R. Yates,et al. The biological impact of mass-spectrometry-based proteomics , 2007, Nature.
[181] Wei-Wei Zhang,et al. Affinity separation and enrichment methods in proteomic analysis. , 2008, Journal of proteomics.
[182] Dieter Stoll,et al. Protein microarrays: catching the proteome , 2005, Mechanisms of Ageing and Development.
[183] D. Ghosh,et al. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. , 2007, Cancer research.
[184] M. Uttamchandani,et al. Peptide microarrays: next generation biochips for detection, diagnostics and high-throughput screening. , 2008, Current pharmaceutical design.
[185] Doriano Fabbro,et al. Tracing pathway activities with kinase inhibitors and reverse phase protein arrays , 2009, Proteomics. Clinical applications.
[186] M. Uhlén,et al. Exploring epitopes of antibodies toward the human tryptophanyl-tRNA synthetase. , 2010, New biotechnology.
[187] David M. Rissin,et al. Single-Molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations , 2010, Nature Biotechnology.
[188] Benito Cañas,et al. Mass spectrometry technologies for proteomics. , 2006, Briefings in functional genomics & proteomics.
[189] A. Wehnert,et al. Engineering Antibody Heavy Chain CDR3 to Create a Phage Display Fab Library Rich in Antibodies That Bind Charged Carbohydrates , 2008, The Journal of Immunology.
[190] Dieter Stoll,et al. Protein microarrays: Promising tools for proteomic research , 2003, Proteomics.
[191] Mathias Uhlen,et al. A pilot project to generate affinity reagents to human proteins , 2008, Nature Methods.
[192] S. Kikuchi,et al. Cystatin C in cerebrospinal fluid as a biomarker of ALS , 2009, Neuroscience Letters.
[193] Dieter Stoll,et al. Protein microarrays for antibody profiling: Specificity and affinity determination on a chip , 2005, Proteomics.
[194] J. E. Chung,et al. Construction of a large synthetic human scFv library with six diversified CDRs and high functional diversity , 2009, Molecules and cells.
[195] R. A. van den Berg,et al. Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.
[196] Ioan Tabus,et al. Dissection of Signaling Pathways in Fourteen Breast Cancer Cell Lines Using Reverse-Phase Protein Lysate Microarray , 2006, Technology in cancer research & treatment.
[197] Edward M. Marcotte,et al. Human Cell Chips: Adapting DNA Microarray Spotting Technology to Cell-Based Imaging Assays , 2009, PloS one.
[198] Stephen R Master,et al. Quality control and protein microarrays. , 2009, Clinical chemistry.
[199] Knut Reinert,et al. Statistical quality assessment and outlier detection for liquid chromatography-mass spectrometry experiments , 2009, BioData Mining.
[200] Pei Wang,et al. The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline , 2008, Proteomics. Clinical applications.
[201] Wei Huang,et al. Serum proteomic signature for cystic fibrosis using an antibody microarray platform. , 2006, Molecular genetics and metabolism.
[202] Yanhui Hu,et al. Genome-Wide Study of Pseudomonas aeruginosa Outer Membrane Protein Immunogenicity Using Self-Assembling Protein Microarrays , 2009, Infection and Immunity.
[203] Guillermo Izquierdo,et al. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis , 2008, Proceedings of the National Academy of Sciences.
[204] Steven A Carr,et al. Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.
[205] Hong Wang,et al. An optimized yeast cell-free system: sufficient for translation of human papillomavirus 58 L1 mRNA and assembly of virus-like particles. , 2008, Journal of bioscience and bioengineering.
[206] J. Kononen,et al. A high‐throughput strategy for protein profiling in cell microarrays using automated image analysis , 2007, Proteomics.
[207] Harald Mischak,et al. Urine in Clinical Proteomics* , 2008, Molecular & Cellular Proteomics.
[208] Stephen R Master,et al. Validation and Quality Control of Protein Microarray-based Analytical Methods , 2008, Molecular biotechnology.
[209] N. Anderson,et al. The Human Plasma Proteome: History, Character, and Diagnostic Prospects , 2003, Molecular & Cellular Proteomics.
[210] Don Simone Daly,et al. An Internal Calibration Method for Protein-Array Studies , 2010, Statistical applications in genetics and molecular biology.
[211] N. Malla,et al. Specific antibody detection in serum, urine and saliva samples for the diagnosis of cystic echinococcosis. , 2007, Acta tropica.
[212] J. Lekakis,et al. Multimarker Approach in Cardiovascular Risk Prediction , 2009, Disease markers.
[213] Ulf Landegren,et al. Sensitive protein detection via triple-binder proximity ligation assays , 2007, Nature Methods.
[214] R. Hilhorst,et al. Peptide microarrays for detailed, high-throughput substrate identification, kinetic characterization, and inhibition studies on protein kinase A. , 2009, Analytical biochemistry.
[215] W. Kuis,et al. Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells , 2003, Clinical Diagnostic Laboratory Immunology.
[216] M. Mehling,et al. A modern approach to CSF analysis: Pathophysiology, clinical application, proof of concept and laboratory reporting , 2009, Clinical Neurology and Neurosurgery.
[217] M. Taussig,et al. Detection of protein-protein interactions by ribosome display and protein in situ immobilisation. , 2009, New biotechnology.
[218] Shaohui Hu,et al. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[219] Peter Nilsson,et al. Validation of serum protein profiles by a dual antibody array approach. , 2009, Journal of proteomics.
[220] Albert Duschl,et al. specimens: systematic evaluation of labeling strategies , 2006 .
[221] Pierre Baldi,et al. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray , 2010, Proceedings of the National Academy of Sciences.
[222] N. Pearce. Corporate influences on epidemiology. , 2008, International journal of epidemiology.
[223] John Löfblom,et al. A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry. , 2008, Protein engineering, design & selection : PEDS.
[224] Erik K. Malm,et al. A Human Protein Atlas for Normal and Cancer Tissues Based on Antibody Proteomics* , 2005, Molecular & Cellular Proteomics.
[225] R J Fulton,et al. Advanced multiplexed analysis with the FlowMetrix system. , 1997, Clinical chemistry.
[226] Renato Tozzoli,et al. Recent advances in diagnostic technologies and their impact in autoimmune diseases. , 2007, Autoimmunity reviews.
[227] Gordon B Mills,et al. Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: Accurate detection of CA19‐9 levels in pancreatic cancer , 2008, Proteomics.
[228] D. Cahill,et al. Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders. , 2010, Journal of proteomics.
[229] L. Liotta,et al. Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.
[230] M. Uhlén,et al. Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies , 2009, Molecular oncology.
[231] Sen-Yung Hsieh,et al. Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling , 2006, Proteomics.
[232] Florian Gnad,et al. Precision Mapping of an In Vivo N-Glycoproteome Reveals Rigid Topological and Sequence Constraints , 2010, Cell.
[233] Y. Hooks,et al. Application of phage display to high throughput antibody generation and characterization , 2007, Genome Biology.
[234] Mathias Uhlén,et al. Affinity as a tool in life science. , 2008, BioTechniques.
[235] P. Nilsson,et al. Screening for C3 Deficiency in Newborns Using Microarrays , 2009, PloS one.
[236] Ruben H. Zamar,et al. MDQC: a new quality assessment method for microarrays based on quality control reports , 2007, Bioinform..
[237] A. Butte,et al. Multiplexed protein array platforms for analysis of autoimmune diseases. , 2006, Annual review of immunology.